Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
European Journal of Heart Failure|May 22, 2016
Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF)Karen Sliwa, Albertino Damasceno, Beth A Davison, et al.
American Heart Journal|April 30, 2017
Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trialPeter S Pang, John R Teerlink, Leandro Boer-Martins, et al.
European Journal of Heart Failure|April 29, 2017
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 studyJohn R Teerlink, Adriaan A Voors, Piotr Ponikowski, et al.
Journal of the American College of Cardiology|March 19, 2013
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failurePeter van der Meer, Douwe Postmus, Piotr Ponikowski, et al.
Journal of the American College of Cardiology|October 11, 2014
Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF studyG Michael Felker, John R Teerlink, Javed Butler, et al.
European Heart Journal|March 11, 2011
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT StudyMarco Metra, Christopher M O'Connor, Beth A Davison, et al.
European Journal of Heart Failure|September 4, 2015
Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF studyGad Cotter, Adriaan A Voors, Margaret F Prescott, et al.
Pageof 12